Market Cap

Myriad Genetics, Inc. Market Capitalization:

$572.3 Million

USD as of Jan. 1, 2026

business Myriad Genetics, Inc. Company Profile

Myriad Genetics, Inc. Main Stock Listing

NASDAQ: MYGN

Market Capitalization History of Myriad Genetics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Myriad Genetics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $572.3 M -50.73%
Jan. 1, 2025 $1.16 B -26.33%
Jan. 1, 2024 $1.58 B 7.08%
Jan. 1, 2023 $1.47 B -32.67%
Jan. 1, 2022 $2.19 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Myriad Genetics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Myriad Genetics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: MYGN

Stock: FSX: MYD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.